2 Beaten-Down Biotech Stocks That Could Bounce Back
Biotech stock investing is full of ups and downs. Anyone who's been watching ChemoCentryx (NASDAQ: CCXI) and Deciphera Pharmaceuticals (NASDAQ: DCPH) lately can tell you all about the downs.
Shares of ChemoCentryx were soaring in 2020 until an FDA advisory committee vote pulled the rug out from under its stock price in May. As a result, shares of the biotech have lost around 77% of their value this year.
Image source: Getty Images.
Source Fool.com